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The pluripotent epiblast (EPI) is the founder tissue of
almost all somatic cells. EPI and primitive endoderm
(PrE) progenitors arise from the inner cell mass (ICM)
of the blastocyst-stage embryo. The EPI lineage
is distinctly identified by its expression of pluripo-
tency-associated factors. Many of these factors
have been reported to exhibit dynamic fluctuations
of expression in embryonic stem cell cultures.
Whether these fluctuations correlating with ICM
fate choice occur in vivo remains an open question.
Using single-cell resolution quantitative imaging of
a Nanog transcriptional reporter, we noted an irre-
versible commitment to EPI/PrE lineages in vivo. A
period of apoptosis occurred concomitantly with
ICM cell-fate choice, followed by a burst of EPI-spe-
cific cell proliferation. Transitions were occasionally
observed from PrE-to-EPI, but not vice versa, sug-
gesting that they might be regulated and not sto-
chastic. We propose that the rapid timescale of early
mammalian embryonic development prevents fluctu-
ations in cell fate.
INTRODUCTION
Pluripotency is defined as the ability of a cell to differentiate and
give rise to all somatic and germ cells (Nichols and Smith, 2012).
Although pluripotency can be induced in differentiated cells
(Takahashi and Yamanaka, 2006), how a pluripotent population
emerges in its native context, within the early mammalian em-
bryo, remains an open question. Insight will come from eluci-
dating the dynamic cell behaviors and molecular mechanisms
underlying the development of the mammalian blastocyst, the
embryonic stage at which a bona fide pluripotent population—
the epiblast (EPI)—is established.
The EPI is molecularly distinct and spatially segregated
from the two extra-embryonic lineages, the primitive endoderm1508 Cell Reports 10, 1508–1520, March 10, 2015 ª2015 The Author(PrE) and trophectoderm (TE) of the mouse blastocyst. The
specification of these lineages occurs as two sequential binary
cell-fate decisions. The first involves specification and segrega-
tion of TE from inner cell mass (ICM), while the second occurs
within the ICM and involves the specification of EPI and PrE
precursors, and their eventual segregation into adjacent tissue
layers (reviewed in Schrode et al., 2013). By late blastocyst
stage, the EPI and PrE lineages are defined both by their position
within the embryo and expression of lineage-specific transcrip-
tion factors, such as NANOG in the EPI, and GATA6 and
GATA4 in the PrE (Xenopoulos et al., 2012). Recent studies
have illustrated that EPI/PrE allocation occurs in at least three
successive steps (Chazaud et al., 2006; Frankenberg et al.,
2011; Plusa et al., 2008). Initially, lineage-specific transcription
factors, such as NANOG and GATA6, are co-expressed by all
ICM cells, suggesting a multi-lineage priming state. Thereafter,
NANOG and PrE lineage-specific transcription factors exhibit
mutually exclusive expression, as lineage progenitors emerge
in a salt-and-pepper distribution within the ICM. At this stage,
GATA4 becomes activated in PrE progenitors, concomitant
with NANOG downregulation. Finally, lineage segregation is
achieved with the localization of PrE cells to the surface of the
ICM. At this time, other pluripotency-associated factors become
restricted to EPI cells, which have become positioned internally
within the ICM. Notably, NANOG is one of the first markers to
be restricted within the EPI, whereas OCT4 and SOX2 become
subsequently downregulated in PrE progenitors and restricted
to EPI progenitors.
The initial specification of EPI and PrE progenitors appears to
occur in a spatially random manner (Schrode et al., 2014) and
could be achieved if a stochastic process were to underlie this
second fate decision. Indeed, an analysis of transcriptomes of
single ICM cells revealed that gene expression is highly hetero-
geneous at earlier stages, exhibiting no apparent lineage speci-
ficity and a hierarchical relationship of marker expression only
appearing in the late blastocyst (Guo et al., 2010; Kurimoto
et al., 2006; Ohnishi et al., 2014).
A degree of heterogeneity has been observed at both protein
and mRNA level for various pluripotency-associated factors in
embryonic stem cell (ESC) cultures. Many studies have focuseds
on Nanog, a central component of the core pluripotency
transcriptional network (Chambers et al., 2007; Kalmar et al.,
2009). Experiments in ESCs have suggested that Nanog expres-
sion displays dynamic fluctuations that may correlate with a
cell’s fate choice between self-renewal and differentiation. How-
ever, it is unclear whether fluctuations in gene expression take
place in vivo in embryos where cell differentiation occurs on a
shorter timescale, nor whether they predict fate choice or fate
reversion. Notably, understanding how pluripotent cells behave
in embryos may provide information that can be reconciled
with observations made in ESCs (Smith, 2013).
To determine how the EPI emerges within the mouse
blastocyst, we generated a reporter of Nanog transcription
(Nanog:H2B-GFP). Derivation of ESCs from reporter-expressing
embryos revealed heterogeneous gene expression asanadapta-
tion toESCpropagation.Using live imaging,wequantified thedy-
namics ofNanog expression in individual cells of live blastocysts,
establishing how Nanog expression influences the fate of ICM
cells. By contrast to ESCs maintained in culture, fluctuations in
Nanog expression between distinct developmental states did
not, generally, occur in vivo. However, we noted rare cases of
cells unidirectionally switching their fate, from a PrE to EPI iden-
tity. Since ICM fate changes were only observed toward the EPI,
and not toward PrE, we concluded that this change was not sto-
chastic. Our analyses also revealed events of selective apoptosis
at the onset of ICM lineage differentiation, followed by a burst of
cell proliferation in EPI-committed cells. Collectively, these data
suggest that, although it may be dynamic in ESCs, the emer-
gence of a pluripotent identity is sequential and linear in vivo
and not accommodating reversibility in fate. In this way, after its
allocation, the pluripotent cell population might be protected,
thereby ensuring the development of somatic lineages.
RESULTS
BAC-Based Nanog Transcriptional Reporters Mark the
Pluripotent State in ESCs and Embryos
To probe the dynamics of the pluripotent state, we developed a
BAC-based Nanog transgenic transcriptional reporter, based on
a previous design used as a readout of cellular reprogramming
during iPS cell generation (Okita et al., 2007) (Figure S1H). For
single-cell resolution readouts of Nanog expression, we gener-
ated nuclear-localized human histone H2B fusion versions of
the reporter (Figures 1A, 1C, and S1E).
To validate transgene activity, we analyzed reporter expres-
sion in transgenic ESCs under various culture conditions. These
conditions included the presence or absence of leukemia
inhibitory factor (LIF), and 2i+LIF, which promote the self-renewal
of ESCs, induce differentiation, or ground state pluripotency,
respectively (Ying et al., 2008). Immunostaining of ESCs in
2i+LIF or serum-LIF conditions revealed markedly increased or
decreased expression, respectively, of both reporter and
NANOGprotein.Heterogeneous but correlatedGFPandNANOG
expression was observed in Nanog:GFPTg/+ and Nanog:H2B-
GFPTg/+ ESCs maintained in serum+LIF conditions (Figures 1A,
1B, S1D, and S1E). Single-cell quantitative image analyses of
immunostained Nanog:H2B-GFPTg/+ ESCs maintained under
different conditions further validated reporter efficacy (FiguresCell1B, S1E, and S1F). Moreover, we observed an increased correla-
tion of reporter activity with NANOG protein for the Nanog:H2B-
GFP transgene, compared to the targeted Nanog transcriptional
reporter in the heterozygous TNGA ESCs (Chambers et al., 2007)
(Figures S1E and S1F). These data suggest that the BAC trans-
genic reporters we constructed faithfully marked the pluripotent
state in ESC cultures and could be used to probeNanog expres-
sion dynamics at single-cell resolution.
Next, we generated Nanog:H2B-GFP transgenic mice for
single-cell resolution quantitative visualization of the EPI lineage
in vivo. We used live imaging to analyze the distribution and
validate the reporter in embryos (Figure 1C). We first observed
reporter activity in embryos at the 8–16 cell stage (Plusa et al.,
2008). Cells displaying high and low GFP levels were first
observed at the mid blastocyst stage (70–100 cells), as a salt-
and-pepper distribution of EPI and PrE precursors was estab-
lished within the ICM (Chazaud et al., 2006; Plusa et al., 2008).
In late blastocysts (>100 cells), where the EPI and PrE lineages
have sorted into distinct layers, cells within the ICM forming
the EPI exhibited significantly elevated levels of GFP compared
to PrE cells located on the surface of the ICM. Thereafter, GFP
was detected within the EPI, albeit at reduced levels in implant-
ing E4.5 and post-implantation E5.5 embryos consistent with the
downregulation of NANOG observed at periimplantation (Cham-
bers et al., 2003). Notably, the reporter was strongly expressed in
TE cells of early and mid blastocysts (corresponding to 32–90
cell stage), possibly resulting from robust NANOG localization in
ICM and TE cells at these stages (Figure S1I) (Dietrich and Hiir-
agi, 2007; Messerschmidt and Kemler, 2010; Morgani et al.,
2013). However, GFP expression in the TE was significantly
reduced in late (>100 cells) and in implanting blastocysts
(Figures 1C and S1G). TE localization was also noted for other
Nanog-based reporters analyzed at comparable embryonic
stages (Figure S1G). Collectively, these data lead us to conclude
that theNanog:H2B-GFP reporter faithfully marks the pluripotent
state both in vitro in ESC cultures and in vivo in the emerging EPI
lineage of the mouse blastocyst.
Derivation of ESCs from Mouse Blastocysts Results in
Highly Variable Pluripotency-Associated Gene
Expression
The EPI lineage of the blastocyst represents the in vivo counter-
part to ESC cultures propagated in vitro (Boroviak et al., 2014).
We therefore sought to investigate the profile of Nanog:H2B-
GFP reporter activity in transgenic embryo-derived ESCs. We
used an ESC derivation protocol in which an ICM outgrowth
emerges in conditions promoting ground state pluripotency in
serum-free medium containing 2i (Czechanski et al., 2014).
Indeed, under these conditions GFP was strongly expressed
by all cells of outgrowths from Nanog:H2B-GFPTg/+ blastocysts
(Figure 1D). However, both reporter and NANOG expression
became heterogeneous when the derived ESCs were propa-
gated under standard serum+LIF conditions, either in the pres-
ence or absence of mouse embryonic feeders (MEFs). Even
in the presence of MEFs, GFP-low/NANOG-low cells were
observed within ESC colonies (Figure 1E). Fluorescence-acti-
vated cell sorting (FACS) and quantitative immunofluorescence
analyses confirmed the presence of a highly heterogeneousReports 10, 1508–1520, March 10, 2015 ª2015 The Authors 1509
Figure 1. BAC-Based Nanog Transcriptional Reporters Faithfully Mark the Pluripotent State in ESCs and Embryos
(A) Immunofluorescence images ofNanog:GFPTg/+ and Nanog:H2B-GFPTg/+ ESCs grown in MEF-free conditions including serum+LIF, 2i+LIF, and serum-LIF for
three passages. Orange arrowheads identify GFP-low and NANOG-low cells within ESC colonies.
(B) Quantitative immunofluorescence analysis after nuclear segmentation of Nanog:H2B-GFPTg/+ ESCs. GFP (y axis) and NANOG (x axis) fluorescence values
plotted for individual ESCs propagated for five passages in MEF-free serum+LIF conditions then grown for 4 days in various culture conditions.
(C) Reporter expression in live embryos stained with membrane marker FM4-64. GFP-hi cells, white arrowheads; GFP-low cells, orange arrowheads; TE cells
expressingGFP, yellow arrowheads. Dashed line depicts boundary between epiblast (EPI) and visceral endoderm (VE) layers of an E5.5 embryo. Cell number was
determined by staining with Hoechst.
(D) Schematic of ESC derivation. After 20 days, Nanog:H2B-GFPTg/+ ESCs were established in the presence of MEF feeders in serum+LIF conditions and then
propagated in the presence or absence of MEFs.
(E) Immunostaining and analysis of derived Nanog:H2B-GFPTg/+ ESCs. Orange arrowheads mark GFP-low/NANOG-low/OCT4+ cells.
(F) FACS analysis of derived Nanog:H2B-GFPTg/+ ESCs grown in serum+LIF conditions in the presence or absence of MEFs. Numbers in FACS histograms
indicate percentage of GFP (left) and GFP+ (right) populations. r = Pearson correlation coefficient. Scale bar represents 20 mm.population, where both reporter and protein expression where
highly correlated (r = 0.85) (Figures 1E and 1F). From these ob-
servations, we conclude that gene expression heterogeneities
of the pluripotent state likely arise in ESCs as a result of their
in vitro propagation.1510 Cell Reports 10, 1508–1520, March 10, 2015 ª2015 The AuthorQuantitative Single-Cell Analysis of Nanog:H2B-GFP
Expression in the Emerging Pluripotent Cells of the
Blastocyst
To determine whether the transgenic reporter allowed a quanti-
tative evaluation of Nanog expression in vivo, we analyzed thes
Figure 2. Differential Expression of
Nanog:H2B-GFP Reporter in Segregating
EPI and PrE Cells
(A) MINS image analysis pipeline (see Experi-
mental Procedures). GFP and NANOG expression
plotted for individual cells after automated nuclear
segmentation and fluorescence intensity normali-
zation (best-fit regression curve).
(B) Immunofluorescence images of fixed Nanog:
H2B-GFPTg/+ embryos. EPI cells, white arrow-
heads; PrE cells, orange arrowheads; TE cells ex-
pressing GFP, yellow arrowheads.
(C) Quantitative immunofluorescence analyses.
(D) Reporter, GATA6, and NANOG expression
in Nanogb-geo/b-geo blastocysts carrying the
Nanog:H2B-GFP reporter. NANOG staining was
absent in Nanog mutant transgenic embryos.
r = Pearson correlation coefficient. Scale bar rep-
resents 20 mm.pattern of reporter expression in transgenic embryos that had
been fixed and stained for lineage-specific markers such as
GATA6/PrE andNANOG/EPI using single-cell quantitative imageCell Reports 10, 1508–1520analysis (Lou et al., 2014) (Figure 2A).
In morulae (8-16 cells) and early blasto-
cyst (32–64 cells) stages, GFP was
observed throughout the embryo, reflect-
ing a double (GATA6+ NANOG+) -positive
state. The differential levels of GFP
expression were evident in mid blasto-
cysts (70–100 cells), as embryos estab-
lished a mutually exclusive distribution of
GATA6+ PrE and NANOG+ EPI progeni-
tors (Figures 2B and S2A). In late blasto-
cysts (>100 cells), where the EPI/PrE
sorting had occurred, reporter expression
was markedly elevated in NANOG+
EPI progenitor cells and diminished in
GATA6+ PrE progenitor cells (Figure 2B).
Quantitative fluorescence analysis of
immunostained Nanog:H2B-GFPTg/+
blastocysts at different stages confirmed
a strong correlation between GFP and
NANOG levels in ICM cells, as seen in
ESCs, thus indicating that the reporter
could be used to quantitatively infer levels
of expression of Nanog (Figures 2C and
S2B). Notably, reporter expression in TE
cells was prominent in early andmid blas-
tocysts but displayed reduced correlation
with NANOG protein compared to the
ICM and hence was not investigated
further (Figures 2C and S2B). The H2B-
GFP reporter responds to changes in
Nanog expression with a characteristic
time that is determined by the stability of
the H2B-GFP fusion protein. Our control
experiments and computational analysisindicate that we can measure changes in Nanog expression
higher than 2-fold with about 1 hr resolution (see the Supple-
mental Experimental Procedures). Such temporal resolution is, March 10, 2015 ª2015 The Authors 1511
Figure 3. Nanog Expression in the ICM Is
Altered by Modulation of FGF Signaling
(A) Immunofluorescence images of late blastocyst
stage Nanog:H2B-GFPTg/+ embryo. Fluorescence
values for GFP and NANOG plotted for individual
cells. Values for GFP and NANOG of ICM cells
also plotted as frequency distributions obtained
by binning fluorescence values in 20 logarithmi-
cally spaced categories, as described previously
(Mun˜oz Descalzo et al., 2012).
(B) Regimen used for exogenous FGF and ERK1/2
inhibitor (ERKi) treatment experiments. Nanog:
H2B-GFPTg/+ blastocysts recovered at E2.75 and
cultured for 36 hr in KSOM medium (I), KSOM +
FGF2 (II), and ERKi (III), followed by staining for
Hoechst, NANOG, and SOX17. White arrowheads
identify NANOG+;SOX17 ICM cells exhibiting
high levels of GFP. Orange arrowheads identify
SOX17+;NANOG;GFP-low ICM cells.
(C) Reporter and NANOG distribution analysis in
cells of cultured embryos shown in (B).
Note that x and y axis scales for scatterplots vary
due to changes in reporter and NANOGexpression
between embryos cultured under different condi-
tions. r = Pearson correlation coefficient. Scale bar
represents 20 mm.much smaller than the timescales of cell differentiation. Finally,
by analyzing Nanog mutant embryos carrying the reporter, we
confirmed that no functional NANOG protein was produced
from the BAC transgene (Figure 2D). We therefore conclude
that the Nanog:H2B-GFP reporter faithfully marks pluripotent1512 Cell Reports 10, 1508–1520, March 10, 2015 ª2015 The Authorscells emerging within the ICM and pro-
vides an accurate quantitative readout of
Nanog expression.
Distribution of NANOG Expression
in the Blastocyst Is Altered by
Modulation of Fibroblast Growth
Factor Signaling
Next, we investigated the distribution of
the Nanog:H2B-GFP transcriptional re-
porter, as well as NANOG protein, as
the EPI compartment emerges within the
ICM of late blastocysts. We performed
quantitative immunofluorescence anal-
ysis on mid-to-late blastocysts (90–110
cells), stained with Hoechst, NANOG,
and the PrE marker SOX17 (Figure 3A).
We noted a bimodal distribution of re-
porter expression within the ICM, which
corresponded to bimodality in NANOG
distribution within prospective EPI and
PrE cells (Figures 3A and S3A–S3D).
We investigated how these distribu-
tions could be modulated by perturbation
of fibroblast growth factor (FGF) signaling,
which plays a critical role in ICM lineage
choice. Pathway inhibition results in anICM composed exclusively of EPI precursors, while incubation
of embryos in exogenous FGF results in an all-PrE ICM
(Chazaud et al., 2006; Kang et al., 2013; Nichols et al., 2009; Ya-
manaka et al., 2010). Consistent with these studies, we observed
that the bimodal distribution of GFP andNANOG levels within the
Figure 4. EPI Cells Emerge In Vivo with an Accompanying Increase in Nanog Expression
(A) Schematic of mouse blastocyst stage embryo development.
(B) Quantification of GFP intensity in individual nuclei of a living Nanog:H2B-GFPTg/+ blastocyst recovered at E3.5 (65 cells) and corresponding images of single
time points. Single-cell intensity traces were obtained by tracking single cells in time-lapse experiments. Mitotic and apoptotic cells were also tracked, resulting in
abrupt peaks in fluorescence intensity. Cells belonging to the ICM are depicted in purple, while TE cells are depicted in green; cells having undergone apoptosis
are depicted as black lines. The developmental timing and the time spanned by tracks analyzed in this panel are illustrated by an arrow in (A).
(C) Top panel, quantification of relative GFP intensity in daughters/sisters versus mother cells upon division in cells of TE (green bars) or ICM (purple bars) origin.
Daughter cells retained expression levels after mitosis, with most changes within 20%.
Data were obtained from the analysis of time-lapse movies of five or more embryos. Bottom panel, cell divisions of EPI progenitors occurring at late blastocyst
stages shown in (B). Red arrowheads identify apoptotic events, and yellow arrowheads mark cell divisions. Scale bar represents 20 mm.ICM was lost when FGF signaling activity was modulated
(Figures 3B, 3C, and S3E–S3J). We therefore conclude that a
heterogeneous distribution of NANOG expression exists in vivo.
This is represented as a stable bimodal distribution within the
ICM and reflects cell fate specification toward PrE and EPI line-
ages, and that this distribution is altered by modulation of FGF
signaling.
Highly Variable Nanog Dynamics Are Initially Observed
Followed by the Establishment of Differential
Expression at the Onset of ICM Lineage Specification
A bimodal distribution of Nanog expression is established as the
pluripotent EPI emerges within the ICM. However, we currently
donot knowwhether fluctuatingexpressionof pluripotency-asso-
ciated factors, such as Nanog, occurs during EPI specification,
nor, if they do exist, whether such fluctuations correlate or predict
state reversions (Smith, 2013). To address this question, we
investigated the behavior of individual ICM cells in Nanog:H2B-
GFPTg/+blastocysts using time-lapse imaging coupledwith quan-
titative image analyses performed in an accurate and automated
fashion (Supplemental Experimental Procedures).CellUsing this methodology, we first observed that in early blasto-
cysts (until 60 cell stage) all cells (ICM and TE) displayed highly
heterogeneous reporter activity (0–400min in Figure 4B), consis-
tent with previous observations (Dietrich and Hiiragi, 2007;
Ohnishi et al., 2014; Plusa et al., 2008). Following this phase,
TE cells downregulated reporter expression, whereas ICM cells
retained or increased their expression, presumably coinciding
with the establishment of a lineage bias (400min to end of movie;
Figure 4B). We also noted apoptotic events, occurring during the
process of lineage specification in randomly positioned GFP-hi
or GFP-low ICM cells (red arrowheads; Figure 4B). As described
previously, apoptotic events occur during blastocyst develop-
ment and are not a consequence of in vitro culture or phototox-
icity (Artus et al., 2013; Plusa et al., 2008). Furthermore, we noted
several cell divisions occurring in GFP-hi ICMcells (yellow arrow-
heads; Figure 4B). Heritability of Nanog:H2B-GFP levels, and
likely cell fate, was observed in all ICM cells after division (Fig-
ure 4C). Of note, an increase in GFP fluorescence was routinely
observed during mitosis, due to chromosome condensation;
thus any resulting rapid oscillations (of the order of 150min) in re-
porter activity were excluded from the analysis, as they were notReports 10, 1508–1520, March 10, 2015 ª2015 The Authors 1513
considered as reflecting changes in gene expression. By using a
computational approach, we confirmed that GFP expression
was not diluted in dividing cells, suggesting that daughter cells
inherited the lineage identity of their parental cell (Figure S4).
Finally, cells within the TE displayed low, somewhat variable
and continually decreasing levels of reporter activity (Figure 4B).
Next, we focused our analyses on subsequent phases of
development, initiating from early-to-mid blastocyst stages (at
around50–60cell) until lateblastocyst stages (ataround100cells),
where the EPI and PrE cells have sorted to their final positions
(Figures 5A and 5B; Movie S1). A subpopulation of ICM cells
is specified to the EPI-lineage, with GFP expression maintained
or increased. By contrast, cells biased toward the PrE lineage
extinguished the reporter during differentiation (Figure 5A).
Infrequent Cell-State Reversals Occur toward, Not Away
from, a Pluripotent Identity
Notably, we observed a few instances where cells in mid-stage
blastocysts, exhibiting low levels of reporter activity, would
rapidly increase reporter activity, and concomitantly become
segregated with the EPI (Figure 5A). These could, in principle,
represent rare PrE-to-EPI conversions. Importantly, we never
observed events of EPI-to-PrE progenitor switching associated
with downregulation ofNanog expression. To obtain an indepen-
dent confirmation of the absence of EPI-to-PrE transitions, we
analyzed time-lapse data from a PrE-specific single-cell resolu-
tion reporter (PdgfraH2B-GFP/+, Plusa et al., 2008). In contrast to
Nanog:H2B-GFP, expression of the PdgfraH2B-GFP reporter is
activated only in PrE-biased cells after cell-fate specification.
Therefore, PrE-to-EPI conversion would be detected as downre-
gulation of the reporter. On the other hand, EPI-to-PrE conver-
sion would give rise to significantly delayed activation of the
reporter in cells lacking expression. We imaged embryos
expressing the PdgfraH2B-GFP reporter starting at the time of
cell differentiation, i.e., the time when expression of the reporter
becomes reliably detectable. We found that all positive cells at
the onset of differentiation retained their expression and no
new cells initiated expression with a significant delay, corre-
sponding to an EPI-to-PrE conversion (Figure 5B). Collectively,
our results with the Nanog:H2B-GFP and PdgfraH2B-GFP/+ re-
porters imply that cell-fate reversals are extremely rare and pref-
erentially happen from the PrE to the EPI state.
The PrE-to-EPI unidirectionality would suggest that fate tran-
sitions are regulated and do not result from purely stochastic
fluctuations in gene expression. To rule out that the inability to
detect EPI-to-PrE transition in Nanog:H2B-GFP embryos was
due to perdurance of GFP reporter, we performed the following
analysis. First, we quantified the dynamics of downregulation of
Nanog:H2B-GFP in PrE cells (Figure S6) and estimated the life-
time of H2B-GFP to be shorter than 4 hr, which is short enough
to detect cell-fate reversal events (details in the Supplemental
Experimental Procedures). Second, we analyzed time-lapse
movies of the Nanog:H2B-GFP reporter in embryos treated
with exogenous FGF (all ICM cells would downregulate NANOG)
and showed that a clear downregulation can be observed (Fig-
ure S5). In addition, we calculated the half-life of H2B-GFP
from time-lapse movies of Nanog:H2B-GFP in exogenous FGF
or cycloheximide (CHX). The decay rates of H2B-GFP in ICM1514 Cell Reports 10, 1508–1520, March 10, 2015 ª2015 The Authorcells in the embryos under CHX or FGF treatments were around
6.5 and 5.5 hr, respectively (Figure S6). Collectively, these exper-
iments allow us to conclude that the half-life of H2B-GFP is
shorter than 6 hr and thus not dissimilar to the half-life of
NANOG, which has been calculated to be approximately 4 hr
(Abranches et al., 2013). Altogether, these results show that
the Nanog:H2B-GFP reporter allows measuring Nanog tran-
scriptional dynamics on timescales longer than 1 hr (see the
Supplemental Experimental Procedures).
At Late Blastocyst Stages, EPI and PrE Do Not Exhibit
Fluctuations
Next, we examined whether fluctuations in Nanog:H2B-GFP,
and thus Nanog, levels were observed after ICM lineage specifi-
cation. At these late blastocyst stages (>90–100 cells), the active
sorting of EPI and PrE populations to adjacent tissue layers is
evident. Our analyses revealed that the EPI cells exhibited
increasing levels of reporter activity, whereas a decrease in
GFP levels was observed in cells forming the emergent PrE
epithelial layer (0 min to end of movie; Figure 5C; Movie S1). At
the end of the specification period, apoptotic events were
observed (red arrowhead; 0–100 min; Figure 5C). Thereafter,
we did not observe any apoptosis. Instead, after ICM lineage
specification, several cell divisions were observed in EPI progen-
itors (yellow arrowheads; Figure 5C). Collectively, these observa-
tions suggest a wave of temporarily restricted apoptotic events,
occurring around the period of lineage specification, followed by
a burst of EPI lineage-specific cell proliferation. Nanog levels re-
mained stable after ICM cell-fate divergence suggesting that
fluctuations between EPI and PrE states do not occur. Based
on these data, we conclude that within the ICM the majority of
pluripotent EPI and extra-embryonic PrE progenitor cells do
not change their fate after specification. Furthermore, our data
lead us to propose that a burst of cell proliferation following
cell differentiation ensures EPI lineage-specific expansion.
Quantitative Analyses of Nanog:H2B-GFP Time-Lapse
Movies Revealed a Correlation between Cell Behaviors
and Cell-Fate Choice within the ICM
Time-lapse imaging in combination with cell tracking and quan-
titative analysis allowed us to determine whether fate reversals
correlate with the spatial position of individual cells within the
ICM. We simultaneously analyzed the position of a cell relative
to the blastocyst cavity, and itsNanog reporter expression levels
as a function of time. Analysis of the spatial distribution of cells
converting from PrE-to-EPI indicated that the cells migrated to-
ward the inner region of the ICM (Figure 6A, blue cell). The cell
undergoing fate switching exhibited similar rate of GFP increase
as in cells of the embryo under conditions of ERK inhibition
(Figure 6B). This observation suggests that the fate switching
might be a result of PrE-biased cells that stop responding to
ERK signaling (due to their localization and fates of their neigh-
bors) and, as a consequence, increase Nanog expression and
change fate. Consistently, under conditions of ERK inhibition,
all ICM cells committed to an EPI fate and displayed increasing
reporter activity, whereas GFP expression in TE cells remained
unaffected, consistent with our previous observations in fixed
embryos (Figures 3B, 3C, and S3E–S3J). Notably, we did nots
Figure 5. State Reversals Can Occur toward a Pluripotent Identity during Lineage Specification in Mid Blastocysts, but Cells Do Not Change
Fate in Late Embryos
(A) Quantification of GFP intensity in single nuclei of a living Nanog:H2B-GFPTg/+ at E3.5 (54 cells) and corresponding snapshots from a time-lapse movie. A
subset of tracks are detailed in the lower plot, corresponding to cells highlighted in the images in the panel on the right. Cell highlightedwith an orange dot and red
outline represents a GFP-low cell that upregulated reporter expression and contributed to EPI.
(B) Quantification of GFP intensity in single nuclei of a living PdgfraH2B-GFP/+ at E3.5 (60 cells) and corresponding snapshot of fluorescence channel overlapped
with bright-field images from a time-lapse movie. Only PrE-biased cells express H2B-GFP.
(C) The same analysis applied in (A) was repeated in a later Nanog:H2B-GFPTg/+ embryo at E3.75 (85 cells). ICM cells segregated toward EPI (red) and PrE
(blue) lineages. Cells that underwent apoptosis depicted with black lines. Red arrowheads mark apoptotic events and yellow arrowheads mark cell divisions.
Tracked nuclei are highlighted by dots; the outline of each dot depicts the lineage choice; red outline depicts EPI progenitor cells; blue outline depicts PrE
progenitor cells. Scale bar represents 20 mm.
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Figure 6. Cell-State Reversals toward a Pluripotent Identity Are Associated with Changes in Position within ICM
Fluorescence levels of single ICM cells (A, left, and B, lower-left panels) and two-dimensional projections of representative space trajectories (A, central, and B,
lower-central panels) are plotted for the duration of time-lapse movies of Nanog:H2B-GFPTg/+ embryo (A) corresponding to embryo in Figure 5A and (B) in the
presence of ERKi. The distance of each cell from the barycenter of the embryo is plotted versus GFP intensity (A, right, and B, lower right).
(A) EPI cells, green and blue; PrE cell, red trajectories. Blue trajectory represents a cell that switched state acquiring an EPI identity, moving from an initial position
on the surface of ICM inward while increasing Nanog expression.
(B) Top, quantification of GFP fluorescence intensities and corresponding snapshots. Bottom, all six trajectories depict the behavior of ICM cells that acquire
an EPI fate increasing reporter activity. All cells change their absolute position due to embryo growth, but there are no events of abrupt spatial change in
position of individual cells within the cohort. Lines represent cell trajectories. Displayed trajectories for mitotic cells were excluded. Unique colors identify
individual cells. The outline of the embryo is drawn for plotting relative position of nuclei. Shades of gray in the trajectory depict time: earlier (light) to later
(darker).observe any apoptotic events during ERK inhibition, whereas a
burst of proliferation was evident in the all-EPI ICM (yellow ar-
rowheads in Figure 6B and Movie S2). These findings support1516 Cell Reports 10, 1508–1520, March 10, 2015 ª2015 The Authorour previous observations, suggesting that apoptosis serves as
a selection mechanism within the ICM, while the proliferation
burst in EPI-committed cells ensures the rapid expansion ofs
the pluripotent lineage after its specification. In addition, we
observed that there was no abrupt spatial position change of
EPI cells within the ICM of ERK inhibitor-treated embryos;
instead, cell motility was restrained, and only passive cell move-
ment was observed as these embryos developed (Figure 6B).
DISCUSSION
Pluripotency-associated factors such as Nanog have been
reported to exhibit dynamic fluctuations of expression in ESC
cultures. Whether fluctuations in gene expression correlating
with cell-state transitions occur in vivo remains an open ques-
tion. Here, we have investigated Nanog expression heterogene-
ities using single-cell resolution Nanog transcriptional reporters
coupled with 3D time-lapse imaging and high-resolution
automated quantitative image analyses. Our data suggest
that BAC-based Nanog:H2B-GFP transgenic reporters are ex-
pressed at physiological levels, exhibit minimal reporter perdur-
ance, and serve as a faithful readout of Nanog expression both
in vitro in ESCs, and in vivo in mouse embryos.
For both ESCs rendered transgenic through introduction of
a Nanog:H2B-GFP construct, as well as transgenic embryo-
derived ESCs, heterogeneities in the levels of reporter, as well
as NANOG protein, were noted. A GFP-low cell population,
which also displayed low levels of NANOG protein, was evident
in cells that were propagated in MEF-free conditions, which
promote a differentiation bias; this population displayed OCT4
expression (Figure 1A, 1B, and S1E), suggesting that it might
consist of pluripotent cells that were actively differentiating
and/or primed for differentiation. Importantly, this variability,
and the presence of a GFP-low/NANOG-low population, in
ESC cultures have also been recently reported with another
Nanog transcriptional reporter (Abranches et al., 2013). These
observations therefore call for caution in the choice of culture
conditions for ESC propagation; hence, it was recently shown
that random monoallelic gene expression could occur stochas-
tically as ESCs differentiated, resulting in the acquisition of
heterogeneities during the adaptation of cells to in vitro culture
(Eckersley-Maslin et al., 2014; Gendrel et al., 2014).
Furthermore, it has been suggested that reporters targeted
to the Nanog locus, which concomitantly ablate Nanog
activity, might exhibit behaviors resulting from Nanog hetero-
zygosity (Faddah et al., 2013; Filipczyk et al., 2013). We noted
that GFP expression from the knockin/knockout TNGA
reporter was elevated compared to a BAC-based Nanog:
GFPTg/+ reporter (Figures S1A–S1C). We therefore investigated
whether Nanog allele heterozygosity per se might result in
increased NANOG expression, consistent with its reported
auto-repressive activity (MacArthur et al., 2012; Navarro et al.,
2012). However, we failed to observe any noticeable difference
in reporter activity between Nanog:H2B-GFPTg/+ ESCs that
harbored a two (wild-type) or one functional Nanog alleles (Fig-
ures S1J and S1K). Thus, our data suggest that the elevated
GFP expression observed in the TNGA ESCs is not the result
of Nanog heterozygosity, and could result from allele design.
The development of a faithful EPI lineage-specific reporter
providing a single-cell resolution quantitative readout of Nanog
expression, coupled with high-resolution image data analysesCellallowed us to address a central open question pertaining the
behavior of EPI cells in vivo. Critical for this type of analysis
was a single-cell resolution live imaging reporter that was suffi-
ciently bright for time-lapse image acquisition, but expressed
at physiological levels, so that reporter perdurance would not
mask downregulation in cells. Notably, our experience with de-
stabilized fluorescent protein reporters reveals reduced levels
of fluorescence, not amenable to the image analyses methodol-
ogies used in this study.
Our data reveal a range of cell behaviors before and after
the pluripotent EPI population has been specified in vivo within
the ICM (Figure 7). Prior to EPI versus PrE specification has
occurred, apoptosis serves as a selective mechanism to ensure
proper segregation of lineage progenitors. Rare fate reversal
events likely occur whereby GFP-low/PrE progenitor cells
convert to a GFP-hi/EPI progenitor state as cells migrate inward
in the ICM. At this time, cell migration correlates with fate choice
and is linked to the presence of a heterogeneous population of
EPI and PrE progenitors. Progenitors could be sorting toward a
niche comprising cells with a similar lineage bias. By contrast,
in the presence of ERK inhibition, lineage choice is forced
toward one direction (all-EPI) resulting in a homogenous ICM
population and is accompanied by a lack of cell movement
(Figure 6B). Finally, after lineage specification hasoccurredwithin
the ICM, fluctuations between EPI and PrE progenitors were not
observed. However, a burst of cell proliferation was observed
in EPI progenitors, as they sorted to the interior of the ICM.
Rarely cells changed their state toward, but never away from,
a pluripotent identity. By using a single-cell resolution reporter
for the PrE lineage, we previously showed that PrE progenitor
cells could downregulate reporter expression but could not
confirm the fate reversal to EPI, as cells could not be followed
after loss of the reporter (Plusa et al., 2008). Here, by using a
single-cell resolution reporter of the EPI lineage, we directly
visualized these transitions. Perhaps cells converting from
PrE-to-EPI might cease responding to an FGF signal, as in
the presence of an ERK-inhibitor, resulting in Nanog upregula-
tion and establishment of pluripotency. These data agree with
recent studies suggesting that pulsatile FGF signaling induces
differential Nanog expression within ICM cells and drives
Nanog mRNA degradation for rapid post-transcriptional control
of pluripotency (Torres-Padilla and Chambers, 2014; Tan and
Elowitz, 2014).
Importantly, we observed no fate reversals between EPI and
PrE subsequent to their specification. This is in agreement with
a recent mathematical model accounting for the dynamics of
the regulatory network that controls ICM differentiation; simula-
tions indicated that after specification cells would not change
identity, and thus EPI and PrE states are not interchangeable
(Bessonnard et al., 2014). In addition, we observed that after
specification a burst of cell proliferation in the pluripotent
compartment was evident. This might ensure adequate numbers
of EPI progenitors available for subsequent development.
Furthermore, our observations suggest that PrE progenitors
exhibit increased plasticity, compared to EPI progenitors,
consistent with recent studies suggesting that PrE progenitors
have a broader developmental potential than their EPI counter-
parts (Grabarek et al., 2012), and observations reporting thatReports 10, 1508–1520, March 10, 2015 ª2015 The Authors 1517
Figure 7. Cell Behaviors during the Emergence of the Pluripotent EPI Lineage
Schematic representation of embryo development frommid-to-late blastocyst. Prior to lineage specification (around 64–80 cells): (1) apoptosis occurs randomly
in EPI or PrE progenitors as they segregate to their appropriate layers, (2) segregation is linked to spatial movements within the ICM, and (3) few GFP-low cells
might acquire a pluripotent identity and migrate inward the ICM. After lineage specification (>80–90 cells): (1) cells do not fluctuate between EPI and PrE states,
and (2) cell divisions occur in EPI-specified population while relocating to the interior of the ICM.ESCs are primed toward endoderm co-express embryonic and
extra-embryonic markers (Morgani et al., 2013).
Our data suggest that once specified in wild-type embryos,
pluripotent cells do not, in general, change their fate. However,
a very limited number of state reversals may occur at this time,
but only toward a pluripotent identity. During development,
sufficient numbers of lineage progenitors must be generated,1518 Cell Reports 10, 1508–1520, March 10, 2015 ª2015 The Authorand there is a time window during which cell-fate reversals can
occur. Moreover, mechanisms involving apoptotic events and
symmetric cell divisions may ensure that a pluripotent identity
is protected and maintained in vivo. These observations within
the embryonic environment appear contrasting with studies in
ESCs. A possible explanation for this apparent disparity could
be that ESCs in culture do not receive the appropriate inputss
from a niche, namely, neighboring cells and extra-cellular com-
ponents. Another could be due to the differential timescales.
ICM cells commit to PrE and EPI fates in less than 24 hr, and,
since development proceeds unidirectionally, even though
there may be non-differentiating (or symmetric) cell divisions,
neither cell population arising within the ICM self-renews. By
contrast, ESCs can be maintained indefinitely in vitro under
conditions of self-renewal, a timescale that presents an unre-
stricted period for conversion between alternative states.
EXPERIMENTAL PROCEDURES
Mouse Husbandry
All animal experiments were approved by the Institutional Animal Care and
Use Committee at the Memorial Sloan Kettering Cancer Center. Mice were
maintained under a 12-hr light-dark cycle. Mouse lines used in this study
were Nanog:H2B-GFPTg/+, Nanogb-geo/+ (Mitsui et al., 2003), and NanogGFP/+
(Hatano et al., 2005). Alleles are schematized in Figure S1H.
Live Embryo Imaging
For live imaging, embryos were cultured in glass-bottomed dishes (MatTek)
in an environmental chamber as done previously (Kang et al., 2013). Live imag-
ing conditions used were compatible with normal development as shown
previously (Plusa et al., 2008). For incubation experiments, an ERK1/ERK2
inhibitor, 1 mM PD0325901 (StemGent), was added to medium 2–3 hr prior
to initiation of 3D time-lapse imaging. GFP was excited using a 488-nm Argon
laser. Live image data were acquired using four laser scanning confocal
imaging systems: Zeiss LSM510META, LSM710, LSM780, and Leica SP8.
Images were acquired using 203/0.75, 403/1.3, or 633/1.4 objectives.
20–30 xy planes separated by 2 mm were acquired per z stack, every
15 min. Movies of 3D time-lapse sequences were compiled and annotated
using QuickTime Pro (Apple).
Immunostaining of ESCs and Embryos
Immunostaining of ESCs and embryos was performed as previously
(Kalmar et al., 2009; Kang et al., 2013; Mun˜oz Descalzo et al., 2012). Primary
antibodies used were CDX2 (1:100, Biogenex), GATA6 (1:100, R&D Systems),
NANOG (1:500, Cosmo Bio), OCT4 (1:100, Santa Cruz Biotechnology), and
SOX17 (1:100, R&D Systems). Secondary Alexa Fluor (Invitrogen) conjugated
antibodies were used at 1:500. DNA was visualized with Hoechst 33342
(5 mg/ml; Invitrogen).
Quantitative Fluorescence Image Analysis
Quantitative fluorescence measurements from images of fixed ESCs and fixed
or live embryos were performed using an automated image processing work-
flow comprising the segmentation of multiple nuclei in 3D data (Figure 2A). The
front-end software, MINS, is a MATLAB (MathWorks)-based graphic user
interface described previously (Lou et al., 2014; http://katlab-tools.org). We
noted that for normalizing fluorescence values of each channel the Hoechst
channel per cell was not optimal to compensate for loss of fluorescence inten-
sity throughout the sample depth (differences in Hoechst fluorescence inten-
sity throughout z stack indicated by orange arrowheads in Figure 2A). We
thus developed an algorithm to generate a regression curve across values of
the Hoechst channel for individual cells (details in the Supplemental Experi-
mental Procedures). Fluorescence values for other channels were normalized
using this curve (Figure 2A). To compare fluorescence values between ICM
and TE cells, TE cells being analyzed needed to be in the same focal plane
as ICM cells. Thus, TE cells positioned at the beginning and end of the z stack
were excluded from the analysis. Only accurately segmented nuclei were
included in analyses.
Nuclear Segmentation and Cell Tracking
Using the segmentation output of the MINS software, we developed an
algorithm for cell tracking. To determine the position of any given cell at a sub-
sequent time point, the algorithm first seeks to identify a clear, well-definedCellminimum in the distance between the cell centroid and the centroids of all cells
in the subsequent frame. If such minimum does not exist, the algorithm uses
cell segmentation to look for maximum overlap between cells at the subse-
quent time point and the cell being tracked. As additional criteria, changes
in nuclear shape and overall distance are required to lie within control ranges.
Such criteria generate unambiguous cell assignments and provide reliable
tracking of a large fraction of cells (60%–70% in this study). The algorithm
was validated by visual inspection, and each track was obtained by matching
forward (prospective) and reverse (retrospective) tracking data (details pro-
vided in the Supplemental Experimental Procedures).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.02.010.
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